Company Filing History:
Years Active: 1983-1984
Title: Toshiaki Nishihata: Innovator in Pharmaceutical Absorption Technologies
Introduction
Toshiaki Nishihata is a notable inventor based in Lawrence, Kansas, who has made significant contributions to the field of pharmaceutical sciences. He holds five patents that focus on enhancing the absorption of various drug forms, particularly antibiotics and rectally administered medications. His innovative approaches aim to improve the efficacy of drug delivery systems.
Latest Patents
One of Nishihata's latest patents is a method for increasing the oral absorption of .beta.-lactam antibiotics. This patent describes a drug form that enhances the absorption of antibiotics such as penicillins and cephalosporins by incorporating a hydroxy aryl or hydroxy aralkyl acid or its derivatives. The presence of these compounds in the drug form is crucial for improving the rate of oral absorption. Another significant patent involves a method and drug form for enhancing the absorption of rectally administered drugs. This invention includes a therapeutically effective dosage of a selected drug combined with hydroxy aryl or hydroxy aralkyl acids or their derivatives, which are essential for increasing the absorption rate when administered rectally.
Career Highlights
Throughout his career, Toshiaki Nishihata has worked with prominent companies in the pharmaceutical industry, including Interx Research Corporation and Merck & Company, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug formulation and delivery.
Collaborations
Nishihata has collaborated with esteemed colleagues such as Takeru Higuchi and Howard J Rytting. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Toshiaki Nishihata's work in enhancing drug absorption methods has made a significant impact on pharmaceutical sciences. His innovative patents reflect his dedication to improving medication efficacy and patient outcomes.